Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570648 · ClinicalTrials.gov registry record · NA
A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00570648 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 50 participants.
The verdict
NCT00570648, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Hypothesis: 1% sodium hyaluronate (Healon), applied at end of surgery to the surface of a corneal transplant will not shorten graft reepithelialization time when compared to coating with nothing. We also wish to measure and compare visual acuity in this immediate post operative period. We also wish to assess the safety of using this agent on the epithelium post-operatively. We will recruit 50 high risk patients (see inclusion criteria) here at the University of Virginia to randomly receive nothing or sodium hyaluronate (Healon) on the ocular surface at the end of surgery, and follow time to reepithelialization of the corneal transplant grafts.
Interventions
- DRUG sodium hyaluronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00570648
The ClinicalTrials.gov registry entry for NCT00570648 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium hyaluronate is the first listed.
NCT00570648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00570648 about?
NCT00570648 is a clinical study titled "A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization". Hypothesis: 1% sodium hyaluronate (Healon), applied at end of surgery to the surface of a corneal transplant will not shorten graft reepithelialization time when compared to coating with nothing. We also wish to measure and compare visual acuity in this immediate post operative period. We also wish ...
What is the current status of trial NCT00570648?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2007-06. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00570648?
The interventions under investigation include: sodium hyaluronate (DRUG).
Who is sponsoring clinical trial NCT00570648?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.